Worby, Colin J.
Kenyon, Cynthia
Lynfield, Ruth
Lipsitch, Marc
Goldstein, Edward
Article History
Received: 28 April 2015
Accepted: 16 July 2015
First Online: 17 August 2015
Competing interests
: ML discloses current grant funding from Pfizer and PATH Vaccine solutions and has consulted for AIR Worldwide and Novartis in the past 3 years. Other authors declare no competing interests.